Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Nowa Sol – page 4

83 clinical trials in Nowa Sol, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Nowa Sol at a glance
83
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

83 trials in Nowa Sol

Open in trial search

Systemic scleroderma

Not recruiting

A study to test if tibulizumab works and is safe for adults with systemic sclerosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tibulizumab
  • Sponsor:Zura Bio Inc.

Psoriasis

Not recruiting

Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Dermatitis atopic

Not recruiting

Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Human IgG1 kappa monoclonal antibody against CRLF2
  • Sponsor:Upstream Bio Inc.

Alopecia areata

Not recruiting

Study on the Effects of Ritlecitinib in Patients Aged 12 and Older with Alopecia Areata

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Psoriatic arthropathy

Not recruiting

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Psoriasis

Not recruiting

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Migraine

Not recruiting

Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Lu Ag09222
  • Sponsor:H. Lundbeck A/S

Psoriatic arthropathy

Not recruiting

Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Myasthenia gravis

Not recruiting

Study on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zilucoplan
  • Sponsor:UCB Biopharma

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Omalizumab
  • Sponsor:Curateq Biologics Private Limited

Dermatitis atopic

Not recruiting

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Nowa Sol

What the registry says about research in the country

01 Rheumatology Studies

Innovative research focusing on psoriatic arthritis and rheumatoid arthritis treatments, evaluating new biological therapies and biosimilars for improved patient outcomes.

  • Zasocitinib for psoriatic arthritis
  • Tocilizumab biosimilar studies
  • Rosnilimab efficacy trials

Multiple studies are investigating novel therapeutic approaches for patients who haven't responded to conventional treatments.

02 Dermatological Conditions

Comprehensive research into atopic dermatitis and plaque psoriasis, including studies for both adult and pediatric populations.

  • Bimekizumab for plaque psoriasis
  • Lunsekimig for atopic dermatitis
  • ADX-914 clinical evaluation

These trials aim to advance treatment options for moderate to severe skin conditions.

03 Autoimmune Disorders

Groundbreaking research in Sjögren's Syndrome and systemic lupus erythematosus, testing novel therapeutic approaches.

  • Dazodalibep safety studies
  • Anifrolumab subcutaneous administration
  • Systemic sclerosis treatments

Focus on developing targeted therapies for complex autoimmune conditions.

04 Neurological Research

Studies addressing epilepsy and Alzheimer's-related conditions, including innovative treatment approaches for seizure management.

  • XEN1101 for seizure control
  • Alzheimer's agitation treatment
  • Staccato alprazolam evaluation

Research aims to improve quality of life for patients with neurological disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.